대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)

  • 제27권3호
  • /
  • Pages.41-52
  • /
  • 2013
  • /
  • 1226-8038(pISSN)
  • /
  • 2287-9463(eISSN)
대한한방소아과학회 (The Association of Korean Oriental Pediatrics)
권호 표지
DOI QR코드

DOI QR Code

Paediatric Allergic Disease Quality of Life Questionnaire (PADQLQ)의 한국어판 개발과 신뢰도, 타당도에 대한 연구

Korean Translation and Validation of the Paediatric Allergic Disease Quality of Life Questionnaire (PADQLQ)

  • 박슬기 (강동경희대학교병원 한방소아과) ;
  • 김세현 (단국대학교 죽전캠퍼스 일반대학원 생명융합학과) ;
  • 이선행 (강동경희대학교병원 한방소아과) ;
  • 장규태 (강동경희대학교병원 한방소아과)
  • Park, Seul Ki (Department of Oriental Pediatrics, Kyung Hee University Hospital at Gang-dong) ;
  • Kim, Sehyun (Department of Medical Consilience, Graduate School, Dankook University) ;
  • Lee, Sun Haeng (Department of Oriental Pediatrics, Kyung Hee University Hospital at Gang-dong) ;
  • Chang, Gyu Tae (Department of Oriental Pediatrics, Kyung Hee University Hospital at Gang-dong)
  • 투고 : 2013.07.26
  • 심사 : 2013.08.14
  • 발행 : 2013.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives In pediatrics of Korean Medicine, it is crucial to evaluate the overall symptoms of children, especially in the children who have serious troubles in their life. In the era when diagnosis in Korean Medicine is quite suitable to evaluate multiple allergic diseases, and when growing numbers are in needs, development of an objective measurement scale for diagnosis of allergic disease in Korean Medicine became essential. Therefore, in the study, pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ) was translated into Korean version with validations on some aspects. Methods In this study, we translated and validated the PADQLQ and established psychometric evidence on its utility in Korean children with similar problems. 71 children, age of 6 ~ 18 with allergic disease has participated. Results The internal consistency reliability of the PADQLQ by Cronbach's ${\alpha}$ was 0.94. In three domains (Practical, Physical, Emotional), the Cronbach's ${\alpha}$ was 0.77, 0.90 and 0.69. The Spearman's rank correlation coefficient between PADQLQ total score and VAS was 0.75 (p<0.001). And, Structural validity was evaluated by the ANOVA test. QoL differences of the four groups in the three domains (practical, physical, emotional) were significant. The item discriminative indices were ranged from 0.1651 to 0.8188. Conclusions Korean version PADQLQ is highly reliable and valid for children with allergic diseases. This is significant to assess the relative seriousness of the allergic diseases and to evaluate the efficacy of different treatments in Korean Medicine.

키워드

참고문헌

  1. Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010;65(2):152-67. https://doi.org/10.1111/j.1398-9995.2009.02244.x
  2. Gershon AS, Guan J, Wang C, To T. Trends in asthma prevalence and incidence in Ontario, Canada, 1996-2005: a population study. Am J Epidemiol 2010;172(6):728-36. https://doi.org/10.1093/aje/kwq189
  3. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics. 2009;123:S131-45. https://doi.org/10.1542/peds.2008-2233C
  4. Bjerg A, Sandstrom T, Lundback B, Ronmark E. Time trends in asthma and wheeze in Swedish children 1996-2006: prevalence and risk factors by sex. Allergy 2010;65(1):48-55. https://doi.org/10.1111/j.1398-9995.2009.02105.x
  5. Hansen TE, Evjenth B, Holt J. Increasing prevalence of asthma, allergic rhinoconjuctivitis and eczema among schoolchildren : three surveys during the period 1985-2008. Acta Paediatr. 2012: Epub ahead of print.
  6. Bjorksten B, Clayton T, Ellwood P, Stewart A, Strachan D; ISAAC Phase III Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008;19(2):110-24. https://doi.org/10.1111/j.1399-3038.2007.00601.x
  7. Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Michell E, Robertson C; and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007;62(9):758-66. https://doi.org/10.1136/thx.2006.070169
  8. Hong SJ, Ahn KM, Lee SY, Kim KE. The Prevalences of Asthma and Allergic Diseases in Korean Children. Pediatr Allergy Respir Dis(Korea). 2008;18:15-25.
  9. Lai CKW, Kim YY, Kuo SH, SpencerM, Williams AE, on behalf of the Asthma Insights and Reality in Asia Pacific Steering Committee. Cost of asthma in the Asia-Pacific region. Eur Respir Rev 2006;15:10-6. https://doi.org/10.1183/09059180.06.00009802
  10. Solans M, Pane S, Estrada MD, Serra-Sutton V, Berra S, Herdman M, Alonso J, Rajmil L. Health-related quality of life measurement in children and adolescents : a systematic review of generic and disease-specific instruments. Value Health. 2008 Jul-Aug;11(4):742-64. https://doi.org/10.1111/j.1524-4733.2007.00293.x
  11. Varni JW, Burwinkle TM, Limbers CA, Szer IS : The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health and quality of life outcomes. 2007;5:9. https://doi.org/10.1186/1477-7525-5-9
  12. Baiardini I, Braido F, Brandi S, Canonica GW. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol. 2006;97:419-28. https://doi.org/10.1016/S1081-1206(10)60928-3
  13. T Chivato, E Valovirta, R Dahl, J de Monchy, A Bloch Thomsen, S Palkonen, L Jacobsen. Allergy, living and learning : Diagnosis and treatment of allergic respiratory diseases in Europe. J Investig Allergol Clin Immunol. 2012;22(3):168-79.
  14. Roberts G, Mylonopoulou M, Hurley C, Lack G. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy. 2005 Oct;35(10):1295-300. https://doi.org/10.1111/j.1365-2222.2005.02333.x
  15. Zheng T, Yu J, OhMH, Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011 Apr; 3(2):67-73. https://doi.org/10.4168/aair.2011.3.2.67
  16. Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol. 2003;111:491-7. https://doi.org/10.1067/mai.2003.138
  17. Ng DK, Wong KC, Chan CH, Ng EP. Development of the Chinese version of the Paediatric Allergic Disease Quality of Life Questionnaire: reliability and validity. Hong Kong Med J. 2011;17:460-4.
  18. Kiotseridis H, Cilio CM, Bjermer L, Jacobsson H, Tunsater A. Swedish translation and validation of the Pediatrid Allergic Disease Quality of Life Questionnaire (PADQLQ). Acta Paediatr. 2011 Feb;100(2):242-7. https://doi.org/10.1111/j.1651-2227.2010.02028.x
  19. Bruyere O, Demoulin M, Brereton C, Humblet F, Flynn D, Hill JC, Maquet D, van Beveren J, Reginster JY, Crielaard JM, Demoulin C. Translation validation of a new back pain screening questionnaire(the STarTBack Screening Tool) in French. Arch Public Health. 2012 Jun 7;70(1):12. https://doi.org/10.1186/0778-7367-70-12
  20. Hong S, Choi GH, Song IS. A clinical study on the Effect of intranasal acupuncture treatment on pediatric allergic rhinitis. J Pediatr Korean Med. 2011;25(2):15-26. https://doi.org/10.7778/jpkm.2011.25.2.015
  21. Ko MJ, Lee YJ, Baek JH. A clinical study on the effect of traditional Korean treatment on pediatric rhinitis. J Pediatr Korean Med. 2011;25(3):12-26. https://doi.org/10.7778/jpkm.2011.25.3.012
  22. Koo JS, Baek JH. A clinical study on the effect of Tongkyu-tang distillate on pediatric allergic rhinitis. J Pediatr Korean Med. 2003;17(2):103-14.

피인용 문헌

  1. Combined Korean medicine therapies in children with allergic rhinitis : A multi-center, observational explanatory registry trial: A study protocol vol.100, pp.51, 2013, https://doi.org/10.1097/md.0000000000028181
  2. House Dust Mite Sublingual Immunotherapy in Children Versus Adults With Allergic Rhinitis vol.35, pp.1, 2013, https://doi.org/10.1177/1945892420931713